TVTX holder plans 10,000-share Rule 144 sale

A holder of TVTX common stock has filed a notice to sell 10,000 shares under Rule 144.

Accepted by SEC EDGAR 01/20/2026 - 04:04 PM EST Learn about SEC filing dates

Rhea-AI Filing Summary

A holder of TVTX common stock has filed a notice to sell 10,000 shares under Rule 144. The shares are to be sold through Morgan Stanley Smith Barney LLC on the NASDAQ, with an indicated aggregate market value of $273,420.00. The filing shows 89,472,327 shares of this class outstanding.

The 10,000 shares were acquired from the issuer on 01/20/2026 through a stock option exercise paid in cash on the same date, and are the securities covered by this planned sale.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

How many TVTX shares are covered by this Form 144 filing?

The notice covers the planned sale of 10,000 shares of common stock, with an indicated aggregate market value of $273,420.00.

How were the TVTX shares in this Form 144 acquired?

The 10,000 common shares were acquired from the issuer on 01/20/2026 through a stock option exercise paid in cash on the same date.

When are the TVTX shares expected to be sold under this Form 144?

The filing lists an approximate date of sale of 01/20/2026 for the 10,000 common shares.

Which broker and exchange are involved in this TVTX Form 144 sale?

The planned sale is through Morgan Stanley Smith Barney LLC Executive Financial Services, and the shares are listed for sale on the NASDAQ.

How many TVTX common shares are outstanding according to this Form 144?

The filing reports 89,472,327 shares of the relevant class of common stock outstanding.

Does this TVTX Form 144 mention any recent sales in the past three months?

The document provides a section for securities sold during the past 3 months, but no specific past sales are detailed in the provided content.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK	0001283303
Filer CCC	XXXXXXXX
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer	TRAVERE THERAPEUTICS, INC.
SEC File Number	001-36257
Address of Issuer	3611 Valley Centre Drive Suite 300 San Diego CALIFORNIA 92130
Phone	888-969-7879
Name of Person for Whose Account the Securities are To Be Sold	ELIZABETH REED
See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.
Relationship to Issuer	Officer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Morgan Stanley Smith Barney LLC Executive Financial Services 1 New York Plaza 8th Floor New York NY 10004	10000	273420.00	89472327	01/20/2026	NASDAQ

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	01/20/2026	Stock Option Exercise	ISSUER			10000	01/20/2026	Cash

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Nothing to Report

144: Remarks and Signature

Remarks
Date of Notice	01/20/2026
Date of Plan Adoption or Giving of Instruction, If Relying on Rule 10b5-1	06/16/2025
ATTENTION:
The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.
Signature	/s/ Elizabeth E. Reed
ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)